According to a new market research study on “North America Medical Polyoxymethylene Market to 2028 - COVID-19 Impact and Analysis and Forecast by: Application,” is expected to reach US$ 15,130.52 thousand by 2028 from US$ 10,319.82 thousand in 2020. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2028. The report provides trends prevailing in the North America medical polyoxymethylene market along with the drivers and restraints pertaining to the market growth. Growing instances of hospital-acquired infections (HAIs) is the major factor driving the growth of the North America medical polyoxymethylene market. However, issues associated with the strict regulations on use of thermoplastics and competition from traditional materials hinder the growth of North America medical polyoxymethylene market.
The North America medical polyoxymethylene market is segmented into application, and country. On the basis of application, the North America medical polyoxymethylene market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. Insulin pen segment dominated the market in 2019. Further, the inhalers segment is expected to be the fastest growing segment during the forecasted period.
The US has the highest number of confirmed cases of coronavirus, among all key countries in the region. This is negatively impacting the chemical and materials industry in the region due to the impact of the COVID-19 pandemic on supply and distribution chains. The ongoing COVID-19 pandemic has drastically altered the growth status of the medical polyoxymethylene industry. The outbreak has distorted operational efficiency and disrupted the value chains due to the sudden shutdown of national and international boundaries, creating revenue loss and damage. The disturbed value chain has had a negative impact on raw material supply. However, as the economies are planning to revive their operations, the demand for medical polyoxymethylene is expected to rise in the coming months. However, the focus over just-in-time production is another factor hindering the medical polyoxymethylene market growth. With the projected rise in the importance of advanced medical equipment and application diversification in post-pandemic times, the demand for medical polyoxymethylene is expected to take huge leaps. Therefore, effective measures taken by such associations, backed by positive government initiatives, to support medical industry is expected to generate the demand for medical polyoxymethylene in the coming years. Further, significant investments by prominent companies in the development of advanced products is, yet, another factor supporting the market growth across North America region.
BASF SE; Celanese Corporation; DuPont de Nemours, Inc.; Ensinger; Kolon Plastics; Korea Engineering Plastics Co. Ltd.; LG Chem; Mitsubishi Chemical Corporation; and Polyplastics Co. Ltd. are among the leading companies in the North America medical polyoxymethylene market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Polyplastics Group expanded its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.
The North America medical polyoxymethylene market is segmented into application, and country. On the basis of application, the North America medical polyoxymethylene market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. Insulin pen segment dominated the market in 2019. Further, the inhalers segment is expected to be the fastest growing segment during the forecasted period.
The US has the highest number of confirmed cases of coronavirus, among all key countries in the region. This is negatively impacting the chemical and materials industry in the region due to the impact of the COVID-19 pandemic on supply and distribution chains. The ongoing COVID-19 pandemic has drastically altered the growth status of the medical polyoxymethylene industry. The outbreak has distorted operational efficiency and disrupted the value chains due to the sudden shutdown of national and international boundaries, creating revenue loss and damage. The disturbed value chain has had a negative impact on raw material supply. However, as the economies are planning to revive their operations, the demand for medical polyoxymethylene is expected to rise in the coming months. However, the focus over just-in-time production is another factor hindering the medical polyoxymethylene market growth. With the projected rise in the importance of advanced medical equipment and application diversification in post-pandemic times, the demand for medical polyoxymethylene is expected to take huge leaps. Therefore, effective measures taken by such associations, backed by positive government initiatives, to support medical industry is expected to generate the demand for medical polyoxymethylene in the coming years. Further, significant investments by prominent companies in the development of advanced products is, yet, another factor supporting the market growth across North America region.
BASF SE; Celanese Corporation; DuPont de Nemours, Inc.; Ensinger; Kolon Plastics; Korea Engineering Plastics Co. Ltd.; LG Chem; Mitsubishi Chemical Corporation; and Polyplastics Co. Ltd. are among the leading companies in the North America medical polyoxymethylene market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Polyplastics Group expanded its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.
The report segments the North America Medical Polyoxymethylene Market as follows:
North America Medical Polyoxymethylene Market - By Application
- Dialysis Machine
- Handles for Surgical Instruments
- Inhalers
- Insulin Pen
- Others
North America Medical Polyoxymethylene Market - By Country
- US
- Canada
- Mexico
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Medical Polyoxymethylene Market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Medical Polyoxymethylene market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving Medical Polyoxymethylene market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Frequently Asked Questions about the North American Medical Polyoxymethylene Market
What is the estimated value of the North American Medical Polyoxymethylene Market?
What is the growth rate of the North American Medical Polyoxymethylene Market?
What is the forecasted size of the North American Medical Polyoxymethylene Market?
Who are the key companies in the North American Medical Polyoxymethylene Market?
Report Attribute | Details |
---|---|
No. of Pages | 91 |
Published | July 2021 |
Forecast Period | 2021 - 2028 |
Estimated Market Value ( USD | $ 10319.82 Million |
Forecasted Market Value ( USD | $ 15130.52 Million |
Compound Annual Growth Rate | 4.9% |
Regions Covered | North America |
Table of Contents
1. Introduction
3. Research Methodology
4. North America Medical Polyoxymethylene Market Landscape
5. North America Medical POM Market - Key Market Dynamics
6. Medical Polyoxymethylene - North America Market Analysis
7. North America Medical Polyoxymethylene Market Analysis -by Application
8. North America Medical POM Market - Country Analysis
9. Impact of COVID-19 Pandemic on North America Medical POM Market
10. Company Profiles
11. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- BASF SE
- Celanese Corporation
- DuPont de Nemours, Inc.
- Ensinger
- Kolon Plastics
- Korea Engineering Plastics Co., Ltd.
- LG Chem
- Mitsubishi Chemical Corporation
- Polyplastics Co., Ltd.